🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted measures to address household expense pressures" in next month's financial statement.

During an interview with media outlets, she stated that lowering price rises is a shared duty of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this calendar year and next.

Potential Utility Cost Interventions

Reports indicate the government could take action to lower utility costs, such as by slashing the current 5% rate of VAT charged on energy supplies.

Another option is to lower some of the government charges presently added to bills.

Fiscal Constraints and Expert Expectations

The administration will obtain the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for these measures.

The expectation from the majority of experts is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her declared debt limits.

Earlier on Thursday, estimates showed there was a £22bn deficit for the chancellor to resolve, which is at the lower end of projections.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the sources of price increases," the Chancellor told reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Pledges and Global Issues

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest figures from the OBR had not altered her pledge to campaign commitments not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with rising international and trade concerns for the Budget tax moves, probably to be focused on those "with the broadest shoulders."

International Economic Tensions

Referring to apprehensions about the UK's economic relations with the Asian nation she said: "Our security interests invariably take priority."

Last week's statement by China to strengthen export controls on critical minerals and other resources that are essential for high-technology manufacturing led US President the US President to suggest an further 100% import tax on goods from the Asian country, raising the risk of an all-out trade war between the two global powers.

The American finance chief labeled the Chinese action "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and causes additional challenges."

"It is my opinion there are sectors where we must confront China, but there are also valuable chances to sell into Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance right."

The Treasury chief also confirmed she was cooperating with other major economies "on our own critical minerals approach, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service spends on medicines could go up as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or scrapping operations in the UK, with some blaming the modest returns they are receiving.

Recently, the government science advisor said the cost the NHS spends on medicines would must go up to stop firms and pharmaceutical investment leaving the UK.

Reeves stated to media: "We have seen because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other European countries."

"The objective is to guarantee that patients getting care from the National Health Service are able to receive the finest critical medicines in the globe. And so we are looking at this situation, and... looking to attract increased funding into Britain."